AZD3759, a BBB-penetrating EGFR inhibitor for the treatment of EGFR mutant NSCLC with CNS metastases

Yang ZGuo QWang YChen KZhang LCheng ZXu YYin XBai YRabbie SKim D.-WAhn M.-JCHIH-HSIN YANGZhang X.2020-05-262020-05-2620161946-6234https://www.scopus.com/inward/record.uri?eid=2-s2.0-85003467426&doi=10.1126%2fscitranslmed.aag0976&partnerID=40&md5=a6a0cb7b889f85e49917f1ae2fad738dhttps://scholars.lib.ntu.edu.tw/handle/123456789/494965[SDGs]SDG3AZD3759, a BBB-penetrating EGFR inhibitor for the treatment of EGFR mutant NSCLC with CNS metastasesjournal article10.1126/scitranslmed.aag0976279280262-s2.0-85003467426